Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy
NCT03885180
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Valve Heart Disease
Anticoagulants; Increased
Interventions
DRUG:
Warfarin Sodium
Sponsor
Wuhan Asia Heart Hospital